ExploreWatchlistsPricing
  1. US-listed companies
  2. Eloxx Pharmaceuticals, Inc.
  3. Financials
  4. Operating income

Eloxx Pharmaceuticals, Inc. (ELOX)

Market cap
$92.56M
P/E ratio
SummaryFinancials
Period EndOperating income (Million USD)YoY (%)
Dec 31, 2025-6-81.30%
Dec 31, 2022-34-47.86%
Dec 31, 2021-66+97.33%
Dec 31, 2020-33-33.82%
Dec 31, 2019-51+6.29%
Dec 31, 2018-48+133.28%
Dec 31, 2017-20+343.95%
Jun 30, 2017-5-58.97%
Jun 30, 2016-11-38.07%
Jun 30, 2015-18+97.61%
Jun 30, 2014-9+96.71%
Jun 30, 2013-5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat